Comparative Analysis of the Neutralizing Capacity of Monovalent and Bivalent Formulations of Betuvax-CoV-2, a Subunit Recombinant COVID-19 Vaccine, Against Various Strains of SARS-CoV-2

SARS-CoV-2, the causal agent of the COVID-19 pandemic, is characterized by rapid evolution, which poses a significant public health challenge. Effective vaccines that provide robust protection, elicit strong immune responses, exhibit favorable safety profiles, and enable cost-effective large-scale p...

Descripció completa

Dades bibliogràfiques

Autors principals:	Anna V. Vakhrusheva, Ekaterina A. Romanovskaya-Romanko, Marina A. Stukova, Maria M. Sukhova, Ksenia S. Kuznetsova, Aleksandr V. Kudriavtsev, Maria E. Frolova, Taras V. Ivanishin, Igor V. Krasilnikov, Artur A. Isaev
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2024-10-01
Col·lecció:	Vaccines
Matèries:	SARS-CoV-2 COVID-19 subunit vaccines bivalent vaccines
Accés en línia:	https://www.mdpi.com/2076-393X/12/10/1200
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!